Zobrazeno 1 - 10
of 16
pro vyhledávání: '"İdris İNCE"'
Autor:
Ibrahim Halil Acar, Muzeyyen Aslaner Ak, Gulsah Akyol, Taha Ulutan Kars, Yildiz Ipek, Ayse Uysal, Figen Atalay, Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Birgul Onec, Hakan Keski, Mufide Okay Ozgeyik, Sebnem Izmir Guner, Esra Terzi Demirsoy, Oktay Bilgir, Birol Guvenc
Publikováno v:
Medicina, Vol 60, Iss 10, p 1623 (2024)
Background and Objectives: Acute myeloid leukemia and myelodysplastic syndrome are both clonal hematologic malignancies that primarily affect older adults. Current treatments for AML/MDS are both limited in number and efficacy. This study aims to eva
Externí odkaz:
https://doaj.org/article/3bac2331ab0843e7ac42188b71925530
Autor:
Ali İhsan GEMİCİ, İstemi SERİN, Vedat Buğra EROL, Mehmet Hilmi DOĞU, İdris İNCE, Rafet EREN, Atakan TEKİNALP, Volkan KARAKUŞ, İklil Nur KOÇ EROL, Zeynep Ece ARSLAN, Zekiye Nur TAY, Elif Nur TUNCER, Ömür Gökmen SEVİNDİK
Publikováno v:
Forbes Tıp Dergisi, Vol 3, Iss 2, Pp 165-172 (2022)
Objective: Both the length of the treatment period and the diversity of the agents used in the treatment significantly affect the quality of life (QoL) of the patients with multiple myeloma (MM). With the aid of the EORTC Quality of Life Questionnair
Externí odkaz:
https://doaj.org/article/72d32f8ee7ef496cb5937c20070d45bb
Autor:
Sinem Civriz Bozdağ, Güldane Cengiz Seval, İpek Yönal Hindilerden, Fehmi Hindilerden, Neslihan Andıç, Mustafa Baydar, Lale Aydın Kaynar, Selami Koçak Toprak, Hasan Sami Göksoy, Berrin Balık Aydın, Ufuk Demirci, Ferda Can, Vildan Özkocaman, Eren Gündüz, Zeynep Tuğba Güven, Zübeyde Nur Özkurt, Sinan Demircioğlu, Meral Beksaç, İdris İnce, Umut Yılmaz, Hilal Eroğlu Küçükdiler, Elgün Abishov, Boran Yavuz, Ünal Ataş, Yaşa Gül Mutlu, Volkan Baş, Fahir Özkalemkaş, Hava Üsküdar Teke, Vildan Gürsoy, Serhat Çelik, Rafiye Çiftçiler, Münci Yağcı, Pervin Topçuoğlu, Özcan Çeneli, Hamza Abbasov, Cem Selim, Muhlis Cem Ar, Orhan Kemal Yücel, Sevil Sadri, Canan Albayrak, Ahmet Muzaffer Demir, Nil Güler, Muzaffer Keklik, Hatice Terzi, Ali Doğan, Zeynep Arzu Yegin, Meltem Kurt Yüksel, Soğol Sadri, İrfan Yavaşoğlu, Hüseyin Saffet Beköz, Tekin Aksu, Senem Maral, Veysel Erol, Leylagül Kaynar, Osman İlhan, Ali Zahit Bolaman, Ömür Gökmen Sevindik, Arzu Akyay, Muhit Özcan, Günhan Gürman, Şule Ünal, Yasemin Yavuz, Reyhan Diz Küçükkaya, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 1, Pp 43-54 (2022)
Objective: Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 infection in highly immunosuppressed populations, such as
Externí odkaz:
https://doaj.org/article/ef03a300a9a44beba39b3be598d50f71
Autor:
İbrahim Halil Açar, Sebnem Izmir Güner, Muzeyyen Aslaner Ak, Mesut Gocer, Erman Ozturk, Figen Atalay, Gulden Sincan, Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Emine Gulturk, Nazli Demir, Ali Dogan, Yildiz Ipek, Birol Guvenc
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 14, Iss 1 (2022)
Objectives: Patients with hematologic malignancies have a high risk of coronavirus disease 2019 (COVID-19) mortality. This study aimed to investigate the impact of COVID-19 on mortality rates in patients with various hematologic malignancies and to d
Externí odkaz:
https://doaj.org/article/84dd9a8b2377465180f49123c3042ffc
Autor:
Filiz Vural, Melda Cömert Özkan, Emin Kaya, Mehmet Sönmez, Mehmet Turgut, İrfan YavaŞoĞlu, Idris Ince, Birol Guvenc, Mahmut Töbü, İsmet Aydoğdu, Güray Saydam, Gülsüm Özet, Volkan Karakuş, Fusun Gediz, Cem Kis, Nur Soyer, İbrahim C. Haznedaroğlu, Alİ Pİr, Gül İlhan, Rıdvan Ali, MÜzeyyen Aslaner, Gökhan Özgür, Fahri Şahin, Asu Fergun Yilmaz, Funda Ceran, Isabel Raika Durusoy Onmuş
Publikováno v:
Turkish Journal of Medical Sciences
Tam Metin / Full Text Q4 SCI-Expanded WOS:000668244900016 PMID: 33315343 The aim of this study is to assess the efficacy and safety of ruxolitinib in patients with myelofibrosis. Materials and methods: From 15 centers, 176 patients (53.4% male, 46.6%
Autor:
Ibrahim Halil, Acar, Sebnem Izmir, Guner, Muzeyyen Aslaner, Ak, Mesut, Gocer, Erman, Ozturk, Figen, Atalay, Gulden, Sincan, Aysun Senturk, Yikilmaz, Omer, Ekinci, Idris, Ince, Emine, Gulturk, Nazli, Demir, Ali, Dogan, Yildiz, Ipek, Birol, Guvenc
Publikováno v:
Mediterranean journal of hematology and infectious diseases. 14(1)
Patients with hematological malignancies have a high risk of mortality from coronavirus disease 2019 (COVID-19). This study aimed to investigate the impact of COVID-19 on mortality rates in patients with various hematological malignancies and to dete
Autor:
Ali Zahit Bolaman, İdris İnce, Zübeyde Nur Özkurt, Elgün Abishov, Ömür Gökmen Sevindik, Hüseyin Saffet Beköz, Ahmet Muzaffer Demir, Irfan Yavasoglu, Veysel Erol, Muzaffer Keklik, Zeynep Arzu Yegin, Arzu Akyay, Vildan Ozkocaman, Hilal Eroğlu Küçükdiler, Münci Yağcı, Meral Beksac, Gunhan Gurman, Cem Selim, Meltem Kurt Yuksel, Ali Dogan, Vildan Gürsoy, Serhat Çelik, Senem Maral, Umut Yilmaz, Leylagül Kaynar, Osman Ilhan, Hava Üsküdar Teke, Güner Hayri Özsan, Berrin Balık Aydın, Ufuk Demirci, Unal Atas, Selami Kocak Toprak, Sinem Civriz Bozdag, Fahir Özkalemkaş, Tekin Aksu, Nil Güler, Guldane Cengiz Seval, Reyhan Diz Küçükkaya, Özcan Çeneli, Yaşa Gül Mutlu, Eren Gündüz, Lale Aydın Kaynar, Sule Unal, Volkan Baş, Boran Yavuz, Pervin Topcuoglu, Hatice Terzi, Fehmi Hindilerden, Zeynep Tuğba Güven, Canan Albayrak, Yasemin Yavuz, Ferda Can, Muhlis Cem Ar, Neslihan Andic, İpek Yönal Hindilerden, Sinan Demircioğlu, Hasan Sami Goksoy, Rafiye Ciftciler, Mustafa Baydar, Soğol Sadri, Muhit Ozcan, Hamza Abbasov, Orhan Kemal Yücel, Sevil Sadri
Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 infection in highly immunosuppressed populations, such as in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a0e580151a54b4a20ef926b2166df4c
https://avesis.deu.edu.tr/publication/details/82513f28-7a67-4796-aeda-6d220d3d7f2b/oai
https://avesis.deu.edu.tr/publication/details/82513f28-7a67-4796-aeda-6d220d3d7f2b/oai
Autor:
Aliihsan Gemici, Istemi Serin, Vedat Buğra Erol, Mehmet Hilmi Doğu, İdris İnce, Rafet Eren, Atakan Tekinalp, Volkan Karakuş, Ömur Gökmen Sevindik
Aim: The aim of our study is to obtain data on the quality of life (QoL) in Hodgkin lymphoma (HL) patients in a representative sample of the general population of Turkey with the help of the EORTC QLQ-C30 and QLQ-HL27 questionnaires. Material and Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56b5ff4cce8439ce4b31e06f21bf1683
https://hdl.handle.net/20.500.12511/10370
https://hdl.handle.net/20.500.12511/10370
Autor:
Volkan Karakuş, Omur Gokmen Sevindik, Aylin Karatas, Emel Merve Yenihayat, Merve Gokcen Polat, Serhat Çelik, Ibrahim Ethem Pinar, Ali Dogan, Idris İnce, Umit Yavuz Malkan, Utku Iltar, Demircan Özdalcı Ozdalcı, Özgür Mehtap, Ramazan Erdem, Murat Kacmaz, Fatma Aykas, Berna Ozturk, Burak Deveci, Aydan Akdeniz, Hale Bulbul, Sureyya Yigit Kaya, Ferda Can, Zeynep Guven, Ceyda Aslan, Muzaffer Keklik, Fahir Ozkalemkas, Hakan Goker, İnci Alacacıoğlu
Introduction: To investigate the demographics and treatment details of the acute myeloid leukemia (AML) patients who were diagnosed and followed up in Turkey. Methods: Patients who were recorded on the database of Turkish AML Registry project were in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d669e7e8d417ece6ac4980d03e59a42
https://hdl.handle.net/20.500.12511/10631
https://hdl.handle.net/20.500.12511/10631
Multipl miyelom tanılı hastalarda EORTC QLQ ile yaşam kalitesi değerlendirmesi: Çok merkezli çalışma
Autor:
Ali İhsan GEMİCİ, İstemi SERİN, Vedat Buğra EROL, Mehmet Hilmi DOĞU, İdris İNCE, Rafet EREN, Atakan TEKİNALP, Volkan KARAKUŞ, İklil Nur KOÇ EROL, Zeynep Ece ARSLAN, Zekiye Nur TAY, Elif Nur TUNCER, Ömür Gökmen SEVİNDİK
Objective: Both the length of the treatment period and the diversity of the agents used in the treatment significantly affect the quality of life (QoL) of the patients with multiple myeloma (MM). With the aid of the EORTC Quality of Life Questionnair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6d037abc8b5c8ce0491f745ffcd1f67
https://hdl.handle.net/20.500.12511/10358
https://hdl.handle.net/20.500.12511/10358